Literature DB >> 32741999

White line disease in a 19-year-old appendix mare.

Leah Ellis1.   

Abstract

A 19-year-old appendix mare was presented with severe, acute right forelimb lameness and a history of significant hoof wall defect. The defect began as progressive toe separation affecting the dorsal hoof wall, which was eventually resected by a farrier. Placement of bar shoes by a farrier to stabilize the hoof was ineffective. Radiographs showed hoof wall separation, palmar rotation, and displacement of the coffin bone, consistent with failure of the laminar structures. Treatment included phenylbutazone, radiographic-guided therapeutic farriery consisting of derotation with a wedge shoe, and restriction to a small, dry paddock. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2020        PMID: 32741999      PMCID: PMC7350061     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  5 in total

Review 1.  Farriery for chronic laminitis.

Authors:  Stephen E O'Grady
Journal:  Vet Clin North Am Equine Pract       Date:  2010-08       Impact factor: 1.792

2.  An investigation of the relationships between angles and shapes of the hoof capsule and the distal phalanx.

Authors:  S J Dyson; C A Tranquille; S N Collins; T D H Parkin; R C Murray
Journal:  Equine Vet J       Date:  2011-05       Impact factor: 2.888

3.  Equine imaging: the framework for applying therapeutic farriery.

Authors:  Randy B Eggleston
Journal:  Vet Clin North Am Equine Pract       Date:  2012-07-18       Impact factor: 1.792

4.  Nonseptic diseases associated with the hoof complex: keratoma, white line disease, canker, and neoplasia.

Authors:  W Rich Redding; Stephen E O'Grady
Journal:  Vet Clin North Am Equine Pract       Date:  2012-08       Impact factor: 1.792

Review 5.  Understanding the Basic Principles of Podiatry.

Authors:  Raul J Bras; Ric Redden
Journal:  Vet Clin North Am Equine Pract       Date:  2018-08       Impact factor: 1.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.